Invokana & Other SGLT2 Inhibitors Lawsuits
Provost Umphrey is seeking justice for those diagnosed with kidney damage, diabetic ketoacidosis or who have suffered amputation
due to the drug Invokana and other SGLT2 inhibitors.
SGLT2 manufactures have failed to warn patients of serious and dangerous side effects linked to their inhibitors. As of April 2019,
there have been 965 Invokana lawsuits and 37 Farxiga lawsuits brought before federal courts.
What are SGLT2 Inhibitors?
SGLT2 inhibitors are FDA approved medications prescribed to patients diagnosed with Type 2 Diabetes. These medications block a protein
in the kidneys called sodium-glucose co-transporter-2, or SGLT2, and allow more glucose to be removed through urine, lowering blood
sugar levels.
SLGT2 inhibitors include the following medications:
- Farxiga
- Jardiance
- Invokamet
- Invokana (the only SGLT2 inhibitor linked to amputation)
FDA Warnings
Invokana, the first of the SGLT2 inhibitor Type 2 Diabetes drug, was approved by the Food and Drug Administration in 2013.
Farxiga and several other drugs in this class were approved in 2014. Starting in 2013, the FDA began releasing Safety Communications,
warning of serious side effects that were linked to the SGLT2 inhibitor when patients began experiencing complications.
Unfortunately, these warnings came too late for some patients having already taken the drug and experiencing dangerous side effects.
Many plaintiffs feel that if they had known of the drugs’ dangers like kidney damage, ketoacidosis and amputation, they would have
never taken the medications.
Symptoms of Diabetic Ketoacidosis
If patients begin to experience any symptoms of ketoacidosis, the FDA recommends discontinuing use of their SGLT2 inhibitors and
immediately seek medical attention. Ketoacidosis arises when the body begins to produce high levels of ketones.
Symptoms include:
- Difficulty breathing
- Nausea or vomiting
- Abdominal pain
- Unusual fatigue or sleepiness
What You Can Do.
If you or a loved one has taken Farxiga, Invokana, Jardiance, or Invokamet and have been diagnosed with kidney damage, diabetic ketoacidosis,
or have suffered amputation, you may be entitled to compensation.
We provide our clients with a guarantee that you will not owe us anything if we are unable to secure financial compensation for your suffering.
All the case information you provide our firm will remain confidential.
If you have concerns of complications due to use of your SGLT2 inhibitor, call our firm today for a free case evaluation at (888) 588-1695.
